Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA ), the E uropean A ssociation of C ardiovascular I maging (EACVI ) and the Cardio‐Oncology C ouncil of the E uropean S ociety of C ardiology (ESC )
Volume: 22, Issue: 9, Pages: 1504 - 1524
Published: Aug 21, 2020
Abstract
Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position statement examines the role of echocardiography, cardiac magnetic resonance, nuclear cardiac imaging and computed tomography in the management of cancer patients. The Imaging and Cardio‐Oncology Study Groups of the Heart Failure Association (HFA) of the European...
Paper Details
Title
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA ), the E uropean A ssociation of C ardiovascular I maging (EACVI ) and the Cardio‐Oncology C ouncil of the E uropean S ociety of C ardiology (ESC )
Published Date
Aug 21, 2020
Volume
22
Issue
9
Pages
1504 - 1524
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History